You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 143 No. 2, February 2007 TABLE OF CONTENTS
  Archives
  •  Online Features
  On the Horizon
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (1)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in this journal
 Topic Collections
 •Immunologic Disorders
 •Pemphigoid
 •Bullous Diseases
 •Photosensitivity Disorders
 •Alert me on articles by topic

The Role of IgE Anti–Basement Membrane Zone Autoantibodies in Bullous Pemphigoid

David T. Woodley, MD

Arch Dermatol. 2007;143(2):249-250.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

INTRODUCTION

Mapping the Binding Sites of Anti-BP180 IgE Autoantibodies in Bullous Pemphigoid
Fairley JA, Ling Fu C, Giudice GJ
J Invest Dermatol. 2005;125:467-472

Bullous pemphigoid (BP) is a subepidermal blistering disease characterized by autoantibodies against the hemidesmosomal protein BP180 (BPAg2, type XVII collagen). NC16A, a noncollagenous stretch of the BP180 ectodomain, is the primary target of pathogenic IgG autoantibodies and IgE class autoantibodies. This study further characterized the IgE-reactive regions of BP180. Of ten sera from untreated BP patients, eight contained IgE reactive with the entire BP180 ectodomain. The IgE in 4 of these 8 sera reacted with NC16A, while in the remaining 4 sera IgE immunoreactivity was restricted to sites downstream of NC16A. In contrast, IgG reactivity to NC16A was detected in 9 of the 10 BP sera, and in the remaining serum, IgG, as well as IgE, reacted exclusively with non-NC16A sites on the . . . [Full Text of this Article]

COMMENT

AUTHOR INFORMATION

Department of Dermatology, Keck School of Medicine, University of Southern California, Los Angeles


RELATED ARTICLES

Childhood Bullous Pemphigoid: Clinical and Immunological Findings in a Series of 4 Cases
Maria Isabel Martinez-De Pablo, Maria Antonia González-Enseñat, Asunción Vicente, Montserrat Gilaberte, and José Manuel Mascaró, Jr
Arch Dermatol. 2007;143(2):215-220.
ABSTRACT | FULL TEXT  

Clinical Evidence of an Intermolecular Epitope Spreading in a Patient With Pemphigus Foliaceus Converting Into Bullous Pemphigoid
Jennifer D. Peterson, Agnes J. Chang, and Lawrence S. Chan
Arch Dermatol. 2007;143(2):272-274.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Correlation of IgE Autoantibody to BP180 With a Severe Form of Bullous Pemphigoid
Iwata et al.
Arch Dermatol 2008;144:41-48.
ABSTRACT | FULL TEXT  

A Call for Papers for On the Horizon
Wood
Arch Dermatol 2007;143:253-254.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.